L

L&C Bio Co Ltd
KOSDAQ:290650

Watchlist Manager
L&C Bio Co Ltd
KOSDAQ:290650
Watchlist
Price: 52 000 KRW -0.95% Market Closed
Market Cap: 1.3T KRW

Income Statement

Earnings Waterfall
L&C Bio Co Ltd

Income Statement
L&C Bio Co Ltd

Rotate your device to view
Income Statement
Currency: KRW
Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024 Dec-2024 Mar-2025 Jun-2025 Sep-2025
Revenue
Interest Expense
18
0
0
0
61
0
0
0
743
0
0
0
460
0
0
0
3 076
0
0
0
6 173
0
0
0
3 221
0
0
0
Revenue
21 241
N/A
22 624
+7%
24 978
+10%
27 348
+9%
29 152
+7%
30 333
+4%
30 410
+0%
31 868
+5%
32 973
+3%
35 141
+7%
37 956
+8%
41 579
+10%
45 677
+10%
47 101
+3%
49 553
+5%
50 399
+2%
52 572
+4%
56 370
+7%
59 716
+6%
67 487
+13%
65 927
-2%
70 635
+7%
72 043
+2%
70 031
-3%
72 093
+3%
73 288
+2%
75 971
+4%
79 981
+5%
Gross Profit
Cost of Revenue
(7 859)
(8 352)
(9 280)
(10 147)
(10 487)
(11 529)
(11 752)
(12 657)
(13 414)
(13 695)
(14 880)
(16 186)
(17 227)
(18 294)
(20 704)
(22 266)
(25 581)
(28 329)
(30 117)
(32 670)
(32 070)
(35 138)
(35 379)
(36 065)
(36 364)
(35 974)
(38 528)
(38 445)
Gross Profit
13 381
N/A
14 271
+7%
15 698
+10%
17 201
+10%
18 664
+9%
18 804
+1%
18 658
-1%
19 211
+3%
19 558
+2%
21 446
+10%
23 076
+8%
25 393
+10%
28 450
+12%
28 807
+1%
28 849
+0%
28 133
-2%
26 992
-4%
28 041
+4%
29 599
+6%
34 818
+18%
33 856
-3%
35 497
+5%
36 665
+3%
33 966
-7%
35 729
+5%
37 314
+4%
37 443
+0%
41 536
+11%
Operating Income
Operating Expenses
(7 905)
(8 543)
(9 091)
(9 679)
(9 632)
(9 902)
(10 210)
(10 387)
(12 235)
(13 801)
(13 743)
(15 283)
(15 280)
(15 591)
(17 101)
(17 406)
(17 508)
(18 466)
(20 623)
(23 262)
(25 727)
(28 206)
(29 661)
(31 541)
(33 187)
(36 869)
(38 569)
(39 940)
Selling, General & Administrative
(6 543)
(7 004)
(7 494)
(7 901)
(8 023)
(8 124)
(9 472)
(10 083)
(9 555)
(12 766)
(11 411)
(12 236)
(12 057)
(11 980)
(13 112)
(13 382)
(13 941)
(14 752)
(16 426)
(18 332)
(20 476)
(21 878)
(23 187)
(24 815)
(25 863)
(28 924)
(30 401)
(31 582)
Research & Development
(1 268)
(1 418)
(1 421)
(1 554)
(1 346)
(1 493)
0
0
(2 381)
(1 505)
(1 961)
(2 445)
(2 295)
(2 521)
(2 786)
(2 728)
(2 195)
(2 139)
(2 341)
(2 823)
(3 152)
(3 946)
(4 042)
(4 190)
(4 907)
(5 196)
(5 107)
(4 934)
Depreciation & Amortization
(93)
(121)
(176)
(224)
(263)
(285)
0
0
(298)
(173)
(371)
(602)
(928)
(1 091)
(1 203)
(1 297)
(1 371)
(1 575)
(1 856)
(2 107)
(2 100)
(2 382)
(2 431)
(2 537)
(2 417)
(2 749)
(3 060)
(3 424)
Other Operating Expenses
0
0
0
0
0
0
(739)
(305)
0
644
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Operating Income
5 477
N/A
5 729
+5%
6 607
+15%
7 522
+14%
9 032
+20%
8 903
-1%
8 448
-5%
8 824
+4%
7 324
-17%
7 645
+4%
9 332
+22%
10 110
+8%
13 170
+30%
13 216
+0%
11 748
-11%
10 726
-9%
9 484
-12%
9 575
+1%
8 977
-6%
11 556
+29%
8 129
-30%
7 291
-10%
7 004
-4%
2 425
-65%
2 542
+5%
445
-82%
(1 126)
N/A
1 595
N/A
Pre-Tax Income
Interest Income Expense
199
339
615
788
834
963
1 174
1 062
5 604
5 233
4 120
4 035
3 580
3 738
3 414
1 488
(5 228)
(6 772)
(6 041)
55 568
57 304
59 036
59 576
(5 834)
135 315
134 669
120 755
71 707
Non-Reccuring Items
0
0
0
0
0
0
0
0
0
0
0
0
5
0
0
0
40
0
0
0
(2 376)
0
0
0
(17)
0
0
0
Gain/Loss on Disposition of Assets
198
0
0
0
0
0
0
0
0
0
0
0
43
0
0
0
76
0
0
0
171
0
0
0
(211)
0
0
0
Total Other Income
16
226
29
45
55
45
63
23
16
112
111
(146)
298
221
416
698
191
270
68
74
38
(2 051)
(2 178)
(2 375)
163
(198)
(280)
391
Pre-Tax Income
5 891
N/A
6 294
+7%
7 252
+15%
8 355
+15%
9 922
+19%
9 910
0%
9 684
-2%
9 908
+2%
12 944
+31%
12 990
+0%
13 564
+4%
13 999
+3%
17 095
+22%
17 175
+0%
15 578
-9%
12 912
-17%
4 563
-65%
3 072
-33%
3 003
-2%
67 198
+2 137%
63 266
-6%
64 276
+2%
64 401
+0%
(5 783)
N/A
137 792
N/A
134 916
-2%
119 349
-12%
73 693
-38%
Net Income
Tax Provision
(796)
(820)
(1 192)
(1 331)
(1 468)
(1 203)
(1 121)
(1 163)
(796)
(184)
(375)
(629)
(1 515)
(2 527)
(2 240)
(1 674)
1 129
1 566
1 866
(13 164)
(14 407)
(14 515)
(14 923)
105
5 445
5 808
6 139
6 248
Income from Continuing Operations
5 094
5 474
6 060
7 023
8 454
8 707
8 564
8 746
12 149
12 806
13 188
13 369
15 580
14 648
13 338
11 238
5 692
4 638
4 869
54 034
48 859
49 761
49 478
(5 678)
143 237
140 723
125 488
79 941
Income to Minority Interest
113
47
(199)
(519)
(1 204)
(1 419)
(1 585)
(1 532)
(1 336)
(1 699)
(2 042)
(2 348)
(1 766)
(1 472)
(808)
(147)
(1 148)
(756)
(755)
(442)
(242)
(448)
(470)
(283)
(546)
(11)
511
(229)
Net Income (Common)
5 208
N/A
5 521
+6%
5 860
+6%
6 505
+11%
7 250
+11%
7 288
+1%
6 978
-4%
7 213
+3%
10 813
+50%
11 107
+3%
11 146
+0%
11 021
-1%
13 814
+25%
13 176
-5%
12 530
-5%
11 092
-11%
4 544
-59%
3 882
-15%
4 114
+6%
53 593
+1 203%
48 361
-10%
49 313
+2%
49 008
-1%
(5 961)
N/A
141 064
N/A
139 085
-1%
124 288
-11%
78 000
-37%
EPS (Diluted)
274.1
N/A
249.83
-9%
267.59
+7%
294.33
+10%
329.54
+12%
329.75
+0%
314.34
-5%
327.87
+4%
491.5
+50%
507.69
+3%
503.96
-1%
485.66
-4%
619.55
+28%
580.84
-6%
552.35
-5%
488.94
-11%
200.32
-59%
171.11
-15%
181.35
+6%
2 362.48
+1 203%
1 956.17
-17%
2 173.83
+11%
2 160.37
-1%
-262.78
N/A
5 599.75
N/A
6 131.16
+9%
5 254.01
-14%
3 469.05
-34%